BCL2 and Alzheimer disease: Hence, BCL2, which inhibits both IP3Rs and ryanodine receptors, is an attractive target to suppress deranged Ca2+ signaling in AD.72,469 Moreover, endogenous ryanodine receptors/BCL2 complexes have been identified in neuronal samples,72 though whether those are dysregulated in AD awaits further validation.